4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Relmada Therapeutics, Inc. (RLMD) operates in the Biotechnology industry and is headquartered in Coral Gables, United States with about 17 employees. Its market capitalization is roughly $677 million. In the fiscal year ended 2025-12-31, RLMD reported $0M in revenue and ($57M) in net income.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($59M) | ($84M) | ($104M) | ($161M) | — |
| Net Income | ($57M) | ($80M) | ($99M) | ($157M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($20M) | ($20M) | ($10M) | ($10M) | ($18M) |
| Net Income | ($19M) | ($20M) | ($10M) | ($10M) | ($18M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $94M | $46M | $98M | $153M | — |
| Total Liabilities | $8M | $10M | $12M | $12M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RLMD viewer.
About TickerBase · Data methodology & sources